Immunosenescence of ageing

Journal of Pathology

Volumn 211, Issue 2, 2007, Pages 144-156

  Gruver, A L ^a   Hudson, L L ^b   Sempowski, G D ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ageing; B cells; Haematopoiesis; Infectious diseases; T cells; Thymopoiesis; Vaccines

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; CANCER VACCINE; CYTOKINE; DENDRITIC CELL VACCINE; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 7; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4 1BB; MONOCLONAL ANTIBODY OX40; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

AGING; B LYMPHOCYTE; CANCER; CANCER IMMUNOTHERAPY; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESEARCH; DRUG SAFETY; EPITHELIUM CELL; GENETIC CODE; GERIATRIC DISORDER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPATHOLOGY; INFLUENZA; LIFESPAN; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; NONHUMAN; NONVIRAL GENE THERAPY; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; REVIEW; SENESCENCE; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; THYMOCYTE; THYMUS ATROPHY; UNSPECIFIED SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM;

AGED; AGED, 80 AND OVER; AGING; ATROPHY; B-LYMPHOCYTES; BONE MARROW CELLS; COMMUNICABLE DISEASES; HEMATOPOIESIS; HUMANS; LYMPHOID TISSUE; NEOPLASMS; STEM CELLS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; VACCINES;

EID: 33846656968     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2104     Document Type: Review

References (134)

1. Miller RA. Aging and immune function. Int Rev Cytol 1991;124:187-215.
2. Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Ann Rev Immunol 2000;18:529-560.
3. Compston JE. Bone marrow and bone: a functional unit. J Endocrinol 2002;173(3):387-394.
4. Lamberts SW, van den Beld AW, van Dev Lely AJ. The endocrinology of aging. Science 1997;278(5337):419-424.
5. French RA, Broussard SR, Meier WA, Minshall C, Arkins S, Zachary JF, et al. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. Endocrinology 2002;143(2):690-699.
6. Wang CQ, Udupa KB, Xiao H, Lipschitz DA. Effect of age on marrow macrophage number and function. Aging (Milano) 1995;7(5):379-384.
7. Goldsby RA, Kindt TJ, Osborne BA, Kuby J. Immunology (5th edn). W.H. Freeman & Co: New York, 1992.
8. Tsuboi I, Morimoto K, Hirabayashi Y, Li GX, Aizawa S, Mori KJ, et al. Senescent B lymphopoiesis is balanced in suppressive homeostasis: decrease in interleukin-7 and transforming growth factor-beta levels in stromal cells of senescence-accelerated mice. Exp Biol Med (Maywood) 2004;229(6):494-502.
9. Kohn DB, Bauer G, Rice CR, Rothschild JC, Carbonaro DA, Valdez P, et al. A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood 1999;94(1):368-371.
10. de Haan G, Van Zant G. Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood 1999;93(10):3294-3301.
11. Mauch P, Botnick LE, Hannon EC, Obbagy J, Hellman S. Decline in bone marrow proliferative capacity as a function of age. Blood 1982;60(1):245-252.
12. Harrison DE, Zhong RK, Jordan CT, Lemischka IR, Astle CM. Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. Exp Hematol 1997;25(4):293-297.
13. Rebel VI, Miller CL, Eaves CJ, Lansdorp PM. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood 1996;87(8):3500-3507.
14. Liang Y, Van Zant G, Szilvassy SJ. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 2005;106(4):1479-1487.
15. Henckaerts E, Langer JC, Snoeck HW. Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice. Blood 2004;104(2):374-379.
16. Yuan R, Astle CM, Chen J, Harrison DE. Genetic regulation of hematopoietic stem cell exhaustion during development and growth. Exp Hematol 2005;33(2):243-250.
17. Harrison DE. Long-term erythropoietic repopulating ability of old, young, and fetal stem cells. J Exp Med 1983;157(5):1496-1504.
18. Chen J, Astle CM, Harrison DE. Development and aging of primitive hematopoietic stem cells in BALB/cBy mice. Exp Hematol 1999;27(5):928-935.
19. Allman D, Sambandam A, Kim S, Miller JP, Pagan A, Well D, et al. Thymopoiesis independent of common lymphoid progenitors. Nat Immunol 2003;4(2):168-174.
20. Miller JP, Allman D. Linking age-related defects in B lymphopoiesis to the aging of hematopoietic stem cells. Semin Immunol 2005;17(5):321-329.
21. Min H, Montecino-Rodriguez E, Dorshkind K. Effects of aging on the common lymphoid progenitor to pro-B cell transition. J Immunol 2006;176(2):1007-1012.
22. Stephan RP, Sanders VM, Witte PL. Stage-specific alterations in murine B lymphopoiesis with age. Int Immunol 1996;8(4):509-518.
23. Johnson KM, Owen K, Witte PL. Aging and developmental transitions in the B cell lineage. Int Immunol 2002;14(11):1313-1323.
24. Miller JP, Allman D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol 2003;171(5):2326-2330.
25. Sherwood EM, Blomberg BB, Xu W, Warner CA, Riley RL. Senescent BALB/c mice exhibit decreased expression of lambda5 surrogate light chains and reduced development within the pre-B cell compartment. J Immunol 1998;161(9):4472-4475.
26. Stephan RP, Lill-Elghanian DA, Witte PL. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. J Immunol 1997;158(4):1598-1609.
27. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 1998;91(1):75-88.
28. Wells JA, de Vos AM. Structure and function of human growth hormone: implications for the hematopoietins. Annu Rev Biophys Biomol Struct 1993;22:329-351.
29. Hanley MB, Napolitano LA, McCune JM. Growth hormone-induced stimulation of multilineage human hematopoiesis. Stem Cells 2005;23(8):1170-1179.
30. Knyszynski A, Adler-Kunin S, Globerson A. Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow. Brain Behav Immunol 1992;6(4):327-340.
31. Chen BJ, Cui X, Sempowski GD, Chao NJ. Growth hormone accelerates immune recovery following allogeneic T cell-depleted bone marrow transplantation in mice. Exp Hematol 2003;31(10):953-958.
32. Haynes BF, Denning SM, Singer KH, Kurtzberg J. Ontogeny of T cell precursors: a model for the initial stages of human T cell development. Immunol Today 1989;10(3):87-91.
33. Haynes BF, Hale LP. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components. Immunol Res 1998;18(3):175-192.
34. Kaye J. Regulation of T cell development in the thymus. Immunol Res 2000;21(2-3):71-81.
35. Haynes BF. The role of the thymic microenvironment in promotion of early stages of human T cell maturation. Clin Res 1986;34(3):422-431.
36. Haynes BF. Human thymic epithelium and T cell development: current issues and future directions. Thymus 1990;16(3-4):143-157.
37. Sempowski GD, Hale LP, Sundy JS, Massey JM, Koup RA, Douek DC, et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol 2000;164(4):2180-2187.
38. Steinmann GG. Changes in the human thymus during aging. Curr Top Pathol 1986;75:43-88.
39. Steinmann GG, Klaus B, Muller-Hermelink HK. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 1985;22(5):563-575.
40. Scollay RG, Butcher EC, Weissman IL. Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur J Immunol 1980;10(3):210-218.
41. George AJ, Ritter MA. Thymic involution with ageing: obsolescence or good housekeeping? (see comments). Immunol Today 1996;17(6):267-272.
42. Kong FK, Chen CL, Six A, Hockett RD, Cooper MD. T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. Proc Natl Acad Sci USA 1999;96(4):1536-1540.
43. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396(6712):690-695.
44. Sempowski GD, Gooding ME, Liao HX, Le PT, Haynes BF. T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol Immunol 2002;38(11):841-848.
45. Sempowski GD, Hale LP, Sundy JS, Massey JM, Koup RA, Douek DC, et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol 2000;164(4):2180-2187.
46. Hale JS, Boursalian TE, Turk GL, Fink PJ. Thymic output in aged mice. Proc Natl Acad Sci USA 2006;103(22):8447-8452.
47. Jamieson BD, Douek DC, Killian S, Hultin LE, Scripture-Adams DD, Giorgi JV, et al. Generation of functional thymocytes in the human adult. Immunity 1999;10(5):569-575.
48. Sempowski GD, Gooding ME, Liao HX, Le PT, Haynes BF. T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol Immunol 2002;38:841-848.
49. Sempowski G, Thomasch J, Gooding M, Hale L, Edwards L, Ciafaloni E, et al. Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis. J Immunol 2001;166(4):2808-2817.
50. Flores KG, Li J, Sempowski GD, Haynes BF, Hale LP. Analysis of the human thymic perivascular space during aging. J Clin Invest 1999;104(8):1031-1039.
51. Tyan ML. Age-related decrease in mouse T cell progenitors. J Immunol 1977;118(3):846-851.
52. Hartwig M, Steinmann G. On a causal mechanism of chronic thymic involution in man. Mech Ageing Dev 1994;75(2):151-156.
53. Aspinall R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J Immunol 1997;158(7):3037-3045.
54. Plum J, De Smedt M, Leclercq G, Verhasselt B, Vandekerckhove B. Interleukin-7 is a critical growth factor in early human T cell development. Blood 1996;88(11):4239-4245.
55. Lacorazza HD, Guevara Patino JA, Weksler ME, Radu D, Nikolic-Zugic J. Failure of rearranged TCR transgenes to prevent age-associated thymic involution. J Immunol 1999;163(8):4262-4268.
56. Le PT, Lazorick S, Whichard LP, Yang YC, Clark SC, Haynes BF, et al. Human thymic epithelial cells produce IL-6, granulocyte-monocyte-CSF, and leukemia inhibitory factor. J Immunol 1990;145(10):3310-3315.
57. Le PT, Tuck DT, Dinarello CA, Haynes BF, Singer KH. Human thymic epithelial cells produce interleukin 1. J Immunol 1987;138(8):2520-2526.
58. Le PT, Kurtzberg J, Brandt SJ, Niedel JE, Haynes BF, Singer KH. Human thymic epithelial cells produce granulocyte and macrophage colony-stimulating factors. J Immunol 1988;141(4):1211-1217.
59. Galy AH, de Waal Malefyt R, Barcena A, Peterson SM, Spits H. Untransfected and SV40-transfected fetal and postnatal human thymic stromal cells. Analysis of phenotype, cytokine gene expression and cytokine production. Thymus 1993;22(1):13-33.
60. Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-dependent and thymic-independent T cell regeneration after bone marrow transplantation. Blood 2001;97(5):1491-1497.
61. Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996;88(5):1887-1894.
62. von Freeden-Jeffry U, Solvason N, Howard M, Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 1997;7(1):147-154.
63. Kim K, Lee CK, Sayers TJ, Muegge K, Durum SK. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol 1998;160(12):5735-5741.
64. Muegge K, Vila MP, Durum SK. Interleukin-7: a co-factor for V(D)J rearrangement of the T cell receptor beta gene. Science 1993;261(5117):93-95.
65. Andrew D, Aspinall R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 2002;37(2-3):455-463.
66. Sempowski GD, Rhein ME, Scearce RM, Haynes BF. Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy. Eur J Immunol 2002;32:3066-3070.
67. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL. Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J 2001;15(6):879-892.
68. Oberholzer C, Oberholzer A, Bahjat FR, Minter RM, Tannahill CL, Abouhamaze A, et al. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci USA 2001;98:11503-11508.
69. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 1999;104(8):1051-1059.
70. Madiehe AM, Mitchell TD, Harris RB. Hyperleptinemia and reduced TNF-alpha secretion cause resistance of db/db mice to endotoxin. Am J Physiol Regul Integr Comp Physiol 2003;284(3):R763-770.
71. Hick RW, Gruver AL, Ventevogel MS, Haynes BF, Sempowski GD. Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy. J Immunol 2006;177(1):169-176.
72. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394(6696):897-901.
73. Erickson M, Morkowski S, Lehar S, Gillard G, Beers C, Dooley J, et al. Regulation of thymic epithelium by keratinocyte growth factor. Blood 2002;100(9):3269-3278.
74. Sims JE, Williams DE, Morrissey PJ, Garka K, Foxworthe D, Price V, et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med 2000;192(5):671-680.
75. Min D, Taylor PA, Panoskaltsis-Mortari A, Chung B, Danilenko DM, Farrell C, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 2002;99:4592-4600.
76. Sokolov VV, Kaplunova OA, Ovseenko TE. (Age factors in architectonics of the splenic arterial vessels). Morfologiia 2003;124(4):57-60.
77. Cheung HT, Nadakavukaren MJ. Age-dependent changes in the cellularity and ultrastructure of the spleen of Fischer F344 rats. Mech Ageing Dev 1983;22(1):23-33.
78. Pahlavani MA, Richardson A, Cheung HT. Age-dependent changes of the mesenteric lymph node of Fischer F344 rats: morphological and histometric analysis. Mech Ageing Dev 1987;39(2):137-146.
79. Luscieti P, Hubschmid T, Cottier H, Hess MW, Sobin LH. Human lymph node morphology as a function of age and site. J Clin Pathol 1980;33(5):454-461.
80. Connoy AC, Trader M, High KP. Age-related changes in cell surface and senescence markers in the spleen of DBA/2 mice: a flow cytometric analysis. Exp Gerontol 2006;41(2):225-229.
81. Lazuardi L, Jenewein B, Wolf AM, Pfister G, Tzankov A, Grubeck-Loebenstein B. Age-related loss of naïve T cells and dysregulation of T cell/B cell interactions in human lymph nodes. Immunology 2005;114(1):37-43.
82. Weksler ME, Szabo P. The effect of age on the B cell repertoire. J Clin Immunol 2000;20(4):240-249.
83. Miller RA. The aging immune system: primer and prospectus. Science 1996;273(5271):70-74.
84. Yang X, Stedra J, Cerny J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J Exp Med 1996;183(3):959-970.
85. Whisler RL, Williams JW Jr, Newhouse YG. Human B cell proliferative responses during aging. Reduced RNA synthesis and DNA replication after signal transduction by surface immunoglobulins compared to B cell antigenic determinants CD20 and CD40. Mech Ageing Dev 1991;61(2):209-222.
86. Zheng B, Han S, Takahashi Y, Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev 1997;160:63-77.
87. Whisler RL, Grants IS. Age-related alterations in the activation and expression of phosphotyrosine kinases and protein kinase C (PKC) among human B cells. Mech Ageing Dev 1993;71(1-2):31-46.
88. Sato H, Dobashi M. The distribution, immune complex trapping ability and morphology of follicular dendritic cells in popliteal lymph nodes of aged rats. Histol Histopathol 1998;13(1):99-108.
89. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. Newly generated CD4 T cells in aged animals do not exhibit age-related defects in response to antigen. J Exp Med 2005;201(6):845-851.
90. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naïve cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci USA 2003;100(25):15053-15058.
91. Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med 2004;200(12):1613-1622.
92. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996;14:591-617.
93. Song H, Price PW, Cerny J. Age-related changes in antibody repertoire: contribution from T cells. Immunol Rev 1997;160:55-62.
94. Miller RA, Garcia G, Kirk CJ, Witkowski JM. Early activation defects in T lymphocytes from aged mice. Immunol Rev 1997;160:79-90.
95. Nel AE, Slaughter N. T cell activation through the antigen receptor. Part 2: role of signaling cascades in T cell differentiation, anergy, immune senescence, and development of immunotherapy. J Allergy Clin Immunol 2002;109(6):901-915.
96. Effros RB, Walford RL. The immune response of aged mice to influenza: diminished T cell proliferation, interleukin 2 production and cytotoxicity. Cell Immunol 1983;81(2):298-305.
97. Powers DC. Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age (see comment). J Am Geriatr Soc 1993;41(1):1-5.
98. + T lymphocytes during primary influenza infection. Mech Ageing Dev 2002;123(8):1167-1181.
99. + retrovirus expression in aged mice is associated with a decline in the antivirus immune response. Virology 2001;290(2):281-289.
100. +-regulatory T cells from mouse to man. Scand J Immunol 2005;62(1):1-15.
101. Rouse BT, Sarangi PP, Suvas S. Regulatory T cells in virus infections. Immunol Rev 2006;212:272-286.
102. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6(4):353-360.
103. Chatila TA. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 2005;116(5):949-959; quiz, 960.
104. + regulatory T cells. J Leukoc Biol 2006; (in press).
105. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27(1):20-21.
106. Kim JM, Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 2006;212:86-98.
107. + T cells in thymus, cord and adult blood. Immunology 2002;106(2):190-199.
108. Dejaco C, Duftner C, Schirmer M. Are regulatory T cells linked with aging? Exp Gerontol 2006;41(4):339-345.
109. van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS. CD4(+) CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004;50(9):2775-2785.
110. high regulatory T cells are not impaired in patients with primary Sjogren's syndrome. J Autoimmun 2005;24(3):235-242.
111. high regulatory T cells increases with age. Clin Exp Immunol 2005; 140(3):540-546.
112. + T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans - impact of immunosenescence. Clin Immunol 2006; 119(3):307-316.
113. + T cells in aged mice. J Immunol 2006;176(11):6586-6593.
114. + Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003;74(2):296-308.
115. + T reg cells. J Exp Med 2006;203(7):1701-1711.
116. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006;203(7):1693-700.
117. Gann PH. Risk factors for prostate cancer. Rev Urol 2002;4(suppl 5):S3-10.
118. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20(2):197-209.
119. Rosenkranz KM, Bedrosian I, Feng L, Hunt KK, Hartman K, Lucci A, et al. Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center. Am J Surg 2006;192(4):541-544.
120. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997;80(7):1273-1283.
121. Caraco C, Marone U, Botti G, Celentano E, Lastoria S, Mozzillo N. Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy. Eur J Surg Oncol 2006; (in press).
122. Lustgarten J, Dominguez AL, Thoman M. Aged mice develop protective antitumor immune responses with appropriate costimulation. J Immunol 2004;173(7):4510-5451.
123. + T cell tolerance to an endogenous tumor antigen. J Immunol 2006;176(2):974-983.
124. Sharma S, Dominguez AL, Lustgarten J. Aging affect the antitumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol 2006;41(1):78-84.
125. Bridges CB, Winquist AG, Fukuda K, Cox NJ, Singleton JA, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 2000;49(RR-3):1-38.
126. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj C, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006;3:CD004876.
127. de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000;61(1):94-99.
128. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005;366(9492):1165-1174.
129. Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005;365(9461):773-780.
130. Deng Y, Jing Y, Campbell AE, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004;172(6):3437-3446.
131. Swain GR, Ransom J. Universal influenza vaccination recommendations: local health department perspectives. J Publ Health Manag Pract 2006;12(4):317-320.
132. Update: influenza activity - United States, 2004-05 season. Morb Mortal Wkly Rep 2005;54(13):328-331.
133. Schwartz B, Wortley P. Mass vaccination for annual and pandemic influenza. Curr Top Microbiol Immunol 2006;304:131-152.
134. Shoham D. Review: Molecular evolution and the feasibility of an avian influenza virus becoming a pandemic strain - a conceptual shift. Virus Genes 2006;33(2):127-132.